Coloplast ASCLPBF 73 Pretax Margin % is -17.56% as of Mar. 2026. GuruFocus rates CLPBF with a GF Score™ of 73/100 and a GF Value™ of $126.92 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Coloplast AS ranks better than 73.07% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Coloplast AS's Pre-Tax Income for the
three
months ended in Mar. 2026 was $-192 Mil. Coloplast AS's Revenue for the
three
months ended in Mar. 2026 was $1,096 Mil. Therefore, Coloplast AS's pretax margin for the quarter that ended in Mar. 2026 was -17.56%.
The historical rank and industry rank for Coloplast AS's Pretax Margin % or its related term are showing as below:
CLPBF'
s Pretax Margin % Range Over the Past 10 Years
Min: 12.28 Med: 27.92 Max: 32.09
Current: 12.28
CLPBF's Pretax Margin % is ranked better than 73.07% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs CLPBF: 12.28
Coloplast AS (OTCPK:CLPBF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Coloplast AS Pretax Margin % Related Terms
Coloplast AS Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Coloplast AS's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLPBF vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Coloplast AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coloplast AS Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Coloplast AS's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coloplast AS (CLPBF) has a Pretax Margin % of -17.56% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Coloplast AS and its competitors. Over the past decade, Coloplast AS's Pretax Margin % has ranged from 12.28 to 32.09. According to the industry distribution chart, Coloplast AS ranks #220 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 26.9%.
Is Coloplast AS's Pretax Margin % too high?
Coloplast AS's current Pretax Margin % is -17.56%. Over the past 10 years, this metric has ranged from a low of 12.28 to a high of 32.09. Based on the distribution chart, Coloplast AS ranks #220 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Coloplast AS has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #220 out of 817 companies for Pretax Margin %. This puts Coloplast AS in the upper half of its industry. The industry median Pretax Margin % is 2.61. Historically, Coloplast AS's own Pretax Margin % has ranged from 12.28 to 32.09 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current Pretax Margin % is -17.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.92, compared to a current price of $57.41 — trading 54.8% below its estimated fair value. The current Pretax Margin % is -17.56%. Coloplast AS's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Pretax Margin % is -17.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coloplast AS (CLPBF) Overvalued in 2026?
Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued.
The current stock price of $57.41 is trading 54.8% below its estimated GF Value™ of $126.92.
GuruFocus considers Coloplast AS to be Significantly Undervalued.
Key valuation signals for CLPBF:
Pretax Margin %: -17.56%
GF Value™: $126.92 vs. price of $57.41 (54.8% below fair value)
No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
73GF Score
Get the complete analysis for CLPBF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLPBF has been successfully added to your 
